BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $81,000 | -58.9% | 75,000 | -58.1% | 0.00% | – |
| Q1 2018 | $197,000 | +8.8% | 179,000 | +23.4% | 0.00% | – |
| Q3 2016 | $181,000 | -80.3% | 145,000 | -81.8% | 0.00% | -100.0% |
| Q2 2016 | $919,000 | +727.9% | 795,000 | +1035.7% | 0.00% | – |
| Q2 2015 | $111,000 | -51.1% | 70,000 | -53.3% | 0.00% | – |
| Q1 2015 | $227,000 | +24.0% | 150,000 | 0.0% | 0.00% | – |
| Q4 2014 | $183,000 | -16.1% | 150,000 | -25.0% | 0.00% | – |
| Q3 2014 | $218,000 | +38.0% | 200,000 | +33.3% | 0.00% | – |
| Q2 2014 | $158,000 | -91.4% | 150,000 | -91.0% | 0.00% | -100.0% |
| Q1 2014 | $1,846,000 | +94.5% | 1,663,000 | +85.8% | 0.00% | +100.0% |
| Q4 2013 | $949,000 | – | 895,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |